Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by askretkaon Mar 25, 2021 7:29am
349 Views
Post# 32873468

For Kswdelux

For Kswdelux
April 10 is the day not April 15th. I did search on AACR and April 10 Oncolytics biotech is presenting. April 10th 8:30 am. ROCHE is worlds biggest biotech from what I can see from searching. They are heavy in their research spending on Oncology as well. I'm leaning a bit towards the Douglas Loe report I posted. It has a lot of good info in it. And it's a middle of the road target between the high and low targets. Things could change fast here. April 9th is the day I'm looking at as a barometer to see where things stand. ----------------------------- Just realized we have Easter holiday in here as well so fewer trading days until the 9th of April. Definitely an interesting and volatile few months ahead. The CAR-T Pela data at play here as well. Cheers!
<< Previous
Bullboard Posts
Next >>